Disclaimer: This information is intended for educational purposes only and should not be considered medical advice. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's condition, available evidence, and clinical judgment. UpToDate and similar resources are dynamic, and information may change. Always consult the most current guidelines and expert consensus.

Waterhouse Friderichsen Syndrome

Overview

• Definition: Waterhouse Friderichsen Syndrome (WFS) is a rare but rapidly fatal condition characterized by acute, massive bilateral adrenal hemorrhage, leading to acute adrenal insufficiency (adrenal crisis) and profound shock. It is most commonly associated with overwhelming meningococcal sepsis (Neisseria meningitidis), but can be caused by other severe bacterial infections or non-infectious etiologies.
• Epidemiology: WFS is uncommon, primarily affecting children, particularly infants and young children, but can occur at any age. While historically strongly linked to Neisseria meningitidis, other bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa, and Capnocytophaga canimorsus have been implicated. Viral infections (e.g., varicella, influenza) can predispose to bacterial superinfection leading to WFS. Incidence has decreased in countries with widespread meningococcal vaccination, but it remains a critical concern in unvaccinated or immunocompromised populations.
• Classification: Primarily classified by etiology:
  • Infectious WFS: The classic form, overwhelmingly associated with sepsis, most commonly meningococcemia.
  • Non-infectious WFS: Rarer, can result from severe trauma, coagulopathies (e.g., antiphospholipid syndrome, heparin-induced thrombocytopenia), adrenal vein thrombosis, or adrenal tumor hemorrhage.

Pathophysiology

• Mechanism: The underlying mechanism involves a severe systemic inflammatory response, typically due to bacterial endotoxins (e.g., lipopolysaccharide from N. meningitidis) or exotoxins. This leads to:
  1. Endothelial Damage: Widespread microvascular injury, particularly within the adrenal glands, which have a rich and intricate vascular supply.
  2. Disseminated Intravascular Coagulation (DIC): Activation of coagulation cascade, leading to widespread microthrombi formation and consumption of platelets and clotting factors, resulting in both thrombotic and hemorrhagic manifestations.
  3. Adrenal Gland Hemorrhage: The combination of endothelial damage, microthrombi, increased capillary fragility, and coagulopathy (due to DIC) precipitates severe hemorrhage into the adrenal cortex and medulla. The adrenal glands become edematous, necrotic, and engorged with blood.
  4. Acute Adrenal Insufficiency: Massive destruction of adrenal cortical tissue abolishes the production of cortisol and aldosterone, leading to acute adrenal crisis. This manifests as refractory hypotension, hypoglycemia, hyponatremia, and hyperkalemia.
  5. Shock: The septic shock (due to systemic inflammation) is exacerbated by the adrenal crisis, leading to profound, vasopressor-refractory shock and multi-organ dysfunction.
• Risk Factors:
  • Young age (infants and young children)
  • Asplenia (surgical or functional, e.g., sickle cell disease)
  • Complement deficiencies (especially C5-C9, properdin)
  • Immunocompromise (e.g., HIV, malignancy, immunosuppressive therapy)
  • Recent viral illness (e.g., influenza, varicella) preceding bacterial infection
  • Overcrowding (e.g., military recruits, college dorms, daycares)
  • Coagulopathies (e.g., inherited disorders, anticoagulant therapy, antiphospholipid syndrome)
• Protective Factors:
  • Vaccination: Meningococcal conjugate vaccines (MenACWY) and serogroup B meningococcal vaccines (MenB) are highly effective in preventing N. meningitidis infections.
  • Prompt and appropriate antibiotic treatment of bacterial infections and sepsis.
  • Adequate nutritional status.

Clinical Presentation

Signs and Symptoms

WFS presents as a rapidly progressive form of fulminant sepsis, often with a highly characteristic rash. - Cardinal Features: * Acute onset of fever and malaise: Often non-specific initial symptoms. * Rapid deterioration: Progression from mild symptoms to profound shock within hours. * Petechial or Purpuric Rash: Begins as small petechiae, rapidly evolving into larger purpuric lesions and ecchymoses, often coalescing to form "purpura fulminans" (large, irregular, necrotic skin lesions with hemorrhagic bullae). This rash is a hallmark of meningococcemia and WFS. * Profound Hypotension/Shock: Often refractory to aggressive fluid resuscitation and vasopressors, characteristic of adrenal crisis superimposed on septic shock. * Altered Mental Status: Lethargy, confusion, irritability, progressing to coma. * Signs of Adrenal Insufficiency: Hypotension, hypoglycemia, hyponatremia, hyperkalemia, profound weakness. * Signs of DIC: Bleeding from venipuncture sites, mucosal surfaces, purpura fulminans. - Early Signs: * Fever, chills, headache, myalgias, arthralgias. * Nausea, vomiting, diarrhea. * Non-specific rash (maculopapular) evolving into petechiae. * Irritability or lethargy (especially in children). - Advanced Signs: * Widespread purpura fulminans with acral cyanosis and potential for limb loss. * Profound, refractory septic shock with multi-organ dysfunction (renal failure, respiratory failure, cardiac dysfunction). * Coma, seizures. * Severe metabolic derangements. - Atypical Presentations: * Absence or subtlety of the characteristic rash (e.g., in neutropenic patients, or if adrenal hemorrhage is due to non-infectious causes). * Presentation primarily as unexplained refractory shock without clear signs of infection. * Isolated adrenal hemorrhage without systemic sepsis (rare).

Physical Examination

• Inspection:
  • Skin: Initial petechiae (non-blanching pinprick spots) rapidly progressing to purpura (larger, purplish lesions >0.5 cm) and ecchymoses. Purpura fulminans (large, violaceous, necrotic plaques with hemorrhagic bullae and sharply demarcated erythematous borders, often involving extremities and trunk). Mottled skin, acral cyanosis.
  • General: Signs of profound shock (pallor, sweating, decreased capillary refill time >2 seconds), tachypnea, tachycardia.
  • Neurological: Altered level of consciousness (irritability, lethargy, confusion, obtundation, coma), nuchal rigidity (if meningitis present).
• Palpation:
  • Cold, clammy extremities.
  • Weak or absent peripheral pulses.
  • Abdominal tenderness (less common, but possible with large adrenal hematomas).
• Special Tests: No specific special tests for WFS. General sepsis examination and neurological assessment.

Diagnostic Approach

WFS is a clinical diagnosis based on the rapid progression of severe sepsis with a characteristic purpuric rash and refractory shock, strongly suspected to have acute adrenal insufficiency. Confirmation often occurs post-mortem or after aggressive management has been initiated.

History Taking

• Key Questions:
  • Onset and progression of symptoms (fever, rash, headache, vomiting, malaise).
  • Recent exposure to ill contacts, especially those with similar symptoms or known meningococcal disease.
  • Immunization status (meningococcal vaccines).
  • Past medical history: Asplenia, complement deficiencies, other immunocompromising conditions, recent viral infections.
  • Medications (anticoagulants).
  • Any history of previous adrenal insufficiency.
• Red Flags:
  • Rapid onset and progression of a petechial or purpuric rash.
  • Refractory hypotension or shock despite aggressive fluid resuscitation.
  • Rapidly deteriorating mental status.
  • Signs of bleeding or DIC.

Laboratory Tests

• First-Line: Obtain immediately in suspected sepsis/WFS.
  • Complete Blood Count (CBC) with differential: May show leukocytosis or leukopenia, left shift. Thrombocytopenia is common and often severe (<100,000/µL).
  • Basic Metabolic Panel (BMP): Hyponatremia, hyperkalemia, hypoglycemia.
  • Renal and Liver Function Tests: Elevated creatinine, BUN, liver enzymes (signs of multi-organ dysfunction).
  • Coagulation Panel: Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT), elevated D-dimer, decreased fibrinogen (<100 mg/dL), consistent with DIC.
  • Blood Cultures: Essential for identifying the causative organism (e.g., Neisseria meningitidis). Obtain before antibiotics if possible, but do not delay antibiotics.
  • Lactate: Elevated in shock, indicates tissue hypoperfusion.
  • Arterial Blood Gas (ABG): Metabolic acidosis (lactic acidosis).
  • Cortisol Level: Random cortisol level in a critically ill patient with shock should typically be >18 mcg/dL (500 nmol/L). A level <18 mcg/dL, especially if refractory to vasopressors, is highly suggestive of adrenal insufficiency. Do not delay treatment while awaiting results.
• Confirmatory:
  • ACTH (Cosyntropin) Stimulation Test: Gold standard for diagnosing adrenal insufficiency (measure cortisol at 0 and 60 minutes after 250 mcg IV synthetic ACTH). However, rarely performed in the acute, unstable WFS setting due to time constraints and need for immediate treatment.
  • CSF Analysis: If meningitis is suspected and the patient is stable enough for a lumbar puncture (LP) after imaging to rule out cerebral edema/mass effect. Gram stain and culture of CSF may identify the pathogen.
  • Skin Biopsy: From purpuric lesions can show vascular necrosis, thrombosis, and inflammatory infiltrate, and may reveal gram-negative cocci (e.g., meningococci).
• Monitoring:
  • Repeat CBC, electrolytes, coagulation studies, and lactate to monitor disease progression and response to treatment.
  • Continuous glucose monitoring.

Imaging

• Recommended:
  • Abdominal Computed Tomography (CT) Scan: Can visualize adrenal hemorrhage (bilateral adrenal enlargement with high-density areas). It's often performed in a critically ill patient with abdominal pain or undifferentiated shock to rule out other causes, and can incidentally confirm WFS. It may show enlarged, hemorrhagic adrenal glands, sometimes with periadrenal fat stranding.
  • Head CT: If neurological signs are prominent (seizures, focal deficits, severe altered mental status) to rule out cerebral edema, hemorrhage, or other intracranial pathology.
• Advanced:
  • Magnetic Resonance Imaging (MRI): Offers superior soft tissue contrast and may better delineate the extent and age of adrenal hemorrhage, but is usually not practical in an acutely unstable patient.

Management

WFS is a medical emergency requiring immediate, aggressive, and simultaneous management of sepsis, shock, and acute adrenal insufficiency. Time is critical.

Acute Management

• Immediate (First-hour interventions - "Sepsis Bundle" adapted for WFS):
  1. Airway, Breathing, Circulation (ABC): Secure airway (intubation if needed), provide ventilatory support. Establish large-bore IV access (2 peripheral IVs or central venous access).
  2. Fluid Resuscitation: Rapid administration of intravenous crystalloids (e.g., Normal Saline or Lactated Ringer's) at 20-30 mL/kg boluses, repeated as needed to maintain mean arterial pressure (MAP) >65 mmHg (adults) or age-appropriate blood pressure (children). Monitor for fluid overload.
  3. Empiric Broad-Spectrum Antibiotics: Administer within 1 hour of recognition of severe sepsis.
     • Adults: Ceftriaxone 2 g IV every 12-24 hours (or Cefotaxime 2 g IV every 4-6 hours) + Vancomycin 15-20 mg/kg IV (max 2 g) every 8-12 hours. Consider adding Ampicillin if Listeria is suspected (e.g., immunocompromised, elderly). For Capnocytophaga (animal bites/exposure), consider meropenem.
     • Children: Ceftriaxone 100 mg/kg/day IV divided every 12-24 hours (max 4 g/day) + Vancomycin 15 mg/kg IV every 6 hours (max 1 g/dose).
  4. Stress-Dose Corticosteroids: This is critical for adrenal crisis and should be given immediately upon suspicion of WFS/adrenal crisis, without waiting for cortisol results.
     • Adults: Hydrocortisone 100 mg IV bolus, then 50-100 mg IV every 6-8 hours.
     • Children: Hydrocortisone 2 mg/kg IV bolus (max 100 mg), then 1-2 mg/kg IV every 6 hours.
  5. Vasopressors: If hypotension persists despite adequate fluid resuscitation (e.g., >40-60 mL/kg), start vasopressors. Norepinephrine is typically first-line.
     • Norepinephrine: Start at 0.05-0.1 mcg/kg/min IV infusion, titrate to target MAP.
     • Vasopressin: May be added as a second-line agent for refractory shock (0.03 units/min IV infusion for adults).
  6. Glucose Management: Monitor blood glucose closely and treat hypoglycemia aggressively with IV dextrose.
• Stabilization:
  • Source Control: Address any identified source of infection.
  • DIC Management:
    • Platelet transfusions if platelet count <20,000/µL or active bleeding with count <50,000/µL.
    • Fresh Frozen Plasma (FFP) if coagulopathy (prolonged PT/aPTT) with active bleeding.
    • Cryoprecipitate if fibrinogen <100 mg/dL with active bleeding or anticipated invasive procedures.
  • Electrolyte Correction: Address hyponatremia and hyperkalemia.
  • Organ Support: Renal replacement therapy for acute kidney injury, mechanical ventilation for respiratory failure.
• Emergency:
  • Cardiac arrest management per ACLS/PALS guidelines.
  • Management of severe acidosis.

Chronic Management

• Pharmacological:
  • If adrenal destruction is complete or extensive, lifelong hormone replacement therapy for primary adrenal insufficiency will be required.
  • Glucocorticoid Replacement: Hydrocortisone (most common) or prednisone. Doses are individualized based on patient's weight, clinical response, and symptoms. Typical adult daily hydrocortisone dose is 15-25 mg, divided (e.g., 10 mg AM, 5 mg midday, 5 mg PM).
  • Mineralocorticoid Replacement: Fludrocortisone 0.05-0.2 mg orally daily, to replace aldosterone, which is crucial for maintaining blood pressure and electrolyte balance. Doses are adjusted based on serum sodium, potassium, and renin levels.
• Non-pharmacological:
  • Patient Education: Crucial for patients and families on "sick day rules" (increasing steroid dose during illness/stress), carrying emergency hydrocortisone, and wearing a medical alert bracelet/necklace.
  • Diet: Normal sodium intake, unless otherwise medically indicated.
  • Psychological Support: For coping with chronic illness and potential sequelae (e.g., limb amputations).
• Monitoring:
  • Regular follow-up with an endocrinologist.
  • Monitoring of electrolytes (sodium, potassium), blood pressure, weight, and general well-being.
  • Bone density screening due to long-term glucocorticoid use.
  • Assessment of growth and development in children.

Treatment Algorithms

• First-Line:
  1. Rapid recognition of severe sepsis/WFS.
  2. Immediate ABCs, fluid resuscitation, vasopressors as needed.
  3. Empiric broad-spectrum antibiotics (covering N. meningitidis and other common causes).
  4. STAT stress-dose hydrocortisone.
  5. Obtain blood cultures and initial labs.
• Second-Line:
  1. Targeted antibiotics once culture results are available.
  2. Continued critical care support, addressing multi-organ dysfunction.
  3. Management of DIC and other complications.
• Refractory Cases:
  1. Consider alternative vasopressors or adjunctive agents (e.g., IV methylene blue in profound vasoplegic shock, though evidence is limited).
  2. Extracorporeal membrane oxygenation (ECMO) for refractory circulatory or respiratory failure in selected patients at specialized centers.
  3. Investigate for other causes of adrenal insufficiency or shock if response to therapy is atypical.

Complications

• Common:
  • Disseminated Intravascular Coagulation (DIC)
  • Multi-organ failure (Acute Respiratory Distress Syndrome, Acute Kidney Injury, hepatic dysfunction)
  • Refractory shock
  • Metabolic derangements (hypoglycemia, hyponatremia, hyperkalemia, metabolic acidosis)
  • Peripheral ischemia and gangrene, requiring limb amputation (due to purpura fulminans and DIC)
  • Skin necrosis and scarring
  • Neurological deficits (e.g., hearing loss, cognitive impairment, seizures)
  • Meningitis (if meningococcal disease is the cause)
• Serious:
  • Death (mortality rates remain very high)
  • Permanent primary adrenal insufficiency
  • Intracranial hemorrhage
  • Compartment syndrome
• Long-term:
  • Chronic adrenal insufficiency (requiring lifelong hormone replacement)
  • Amputation of limbs or digits
  • Extensive skin scarring requiring grafting
  • Neurodevelopmental delay or cognitive impairment (especially in pediatric survivors)
  • Post-traumatic stress disorder

Prognosis

• Factors:
  • Severity of Sepsis at Presentation: Patients presenting with profound shock and extensive purpura have worse outcomes.
  • Time to Treatment: Rapid administration of antibiotics and corticosteroids significantly improves survival.
  • Etiology: Meningococcal sepsis typically has a more rapid and severe course.
  • Extent of Adrenal Hemorrhage: More extensive hemorrhage correlates with higher mortality and greater likelihood of permanent adrenal insufficiency.
  • Age: Infants and very young children often have a worse prognosis.
  • Comorbidities: Underlying immunocompromise, asplenia, or other severe conditions worsen prognosis.
• Survival: Historically, mortality rates for WFS were extremely high (70-90%). With modern critical care, early antibiotics, and stress-dose corticosteroids, survival rates have improved, but still remain high, ranging from 40-60%.
• Quality of Life: Survivors often face significant long-term morbidity, including chronic adrenal insufficiency, limb loss, extensive skin scarring, and neurological deficits, profoundly impacting their quality of life.

Prevention

• Primary:
  • Vaccination: This is the most effective primary prevention strategy against meningococcal WFS.
    • Meningococcal conjugate vaccines (MenACWY): Protect against serogroups A, C, W, and Y. Recommended for adolescents (11-12 years with a booster at 16 years) and at-risk individuals (e.g., asplenia, complement deficiency, travelers to endemic areas).
    • Serogroup B meningococcal vaccines (MenB): Recommended for adolescents/young adults (16-23 years, preferred 16-18 years) and individuals at increased risk of serogroup B disease.
  • Chemoprophylaxis: For close contacts of patients with confirmed meningococcal disease (e.g., rifampin, ciprofloxacin, ceftriaxone).
  • Prompt Treatment of Bacterial Infections: Early recognition and treatment of any bacterial infection can prevent progression to severe sepsis and WFS.
• Secondary:
  • Early Recognition and Aggressive Treatment of Sepsis: Prompt initiation of sepsis bundles (fluids, antibiotics, vasopressors, and particularly stress-dose corticosteroids in suspected WFS) is crucial to mitigate disease progression and improve outcomes.
• Tertiary:
  • Prevention of Complications: Meticulous wound care for purpura fulminans, physical and occupational therapy for limb injuries, lifelong hormone replacement for adrenal insufficiency, and psychological support to help survivors adapt to chronic conditions and physical changes.

Special Populations

• Pediatric: WFS is more common in children. The clinical course can be extremely rapid. High index of suspicion for WFS in any child with fulminant sepsis, purpuric rash, and refractory shock. Hydrocortisone doses are weight-based. Long-term follow-up for growth, development, and neurocognitive outcomes is essential.
• Geriatric: Less common, but elderly patients may present with atypical symptoms, have more comorbidities, and potentially a delayed diagnosis. Prognosis may be worse due to underlying frailty and reduced physiological reserve.
• Pregnancy: Extremely rare. Management principles remain the same, but consideration must be given to fetal well-being, and certain antibiotics (e.g., ciprofloxacin for prophylaxis) may have restricted use.
• Comorbidities: Patients with asplenia, complement deficiencies, HIV, or other immunocompromised states are at higher risk. Their management requires close attention to the specific susceptibilities and treatment implications of their underlying condition. Anticoagulated patients or those with pre-existing coagulopathies are at increased risk of adrenal hemorrhage.

Clinical Pearls

• Diagnostic:
  • "The Triple Threat": Consider WFS in any patient with the triad of fulminant sepsis, a rapidly progressive purpuric rash, and refractory shock.
  • Don't wait for labs: Initiate stress-dose corticosteroids immediately if WFS is suspected clinically. Delay in administering steroids can be fatal.
  • Meningococcal Disease: Although other pathogens can cause WFS, N. meningitidis is the classic and most aggressive cause. A history of close contact or recent travel should raise suspicion.
• Treatment:
  • Aggressive and Early: Prompt administration of IV fluids, broad-spectrum antibiotics, and stress-dose hydrocortisone are the cornerstones of management and are life-saving.
  • Monitor Glucose and Electrolytes: Hypoglycemia, hyponatremia, and hyperkalemia are common and require active management.
  • DIC Management: Be prepared to manage DIC with blood products as indicated.
• Pitfalls:
  • Delay in Diagnosis: Mistaking early signs for a less severe viral illness.
  • Underestimation of Severity: Not recognizing the rapid progression and high mortality rate.
  • Failure to Administer Steroids: Hesitation to give stress-dose steroids due to awaiting laboratory confirmation or fear of masking infection. In acute WFS, the benefits of prompt steroid administration far outweigh potential risks.
  • Inadequate Resuscitation: Under-resuscitation with fluids or vasopressors, or underdosing of steroids, can lead to irreversible shock.

Recent Updates

• Guidelines: The Surviving Sepsis Campaign guidelines are continuously updated and provide comprehensive, evidence-based recommendations for the management of sepsis and septic shock, which are directly applicable to WFS. These guidelines emphasize early recognition, rapid initiation of antibiotics, fluid resuscitation, and vasopressors, and specific recommendations for corticosteroid use in vasopressor-dependent shock.
• Evidence: Ongoing research focuses on novel therapies for severe sepsis, improved rapid diagnostic methods for identifying pathogens, and understanding the host immune response in meningococcal disease. The role of meningococcal vaccination continues to be critical in reducing incidence.
• Controversies: Optimal timing and duration of corticosteroid therapy in septic shock, and specifically in WFS, continue to be debated. The utility of specific adjunctive therapies for DIC or severe purpura fulminans (e.g., protein C concentrate, fresh frozen plasma) is an area of ongoing study.

Key References

1. Surviving Sepsis Campaign Guidelines: Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2016. Crit Care Med. 2017 Mar;45(3):486-552. (Updates are published periodically).
2. Meningococcal Disease Management: Centers for Disease Control and Prevention (CDC) guidelines for the diagnosis and management of meningococcal disease.
3. Adrenal Crisis Management: Arlt W, et al. Consensus Statement on the Diagnosis, Treatment and Follow-up of Patients with Primary Adrenal Insufficiency. J Clin Endocrinol Metab. 2014;99(11):3939-3963.
4. Review Article on WFS: Bossi P, et al. Waterhouse-Friderichsen Syndrome: A Clinical Review. Med Mal Infect. 2016;46(8):397-402. (While this reference is a few years old, the core clinical aspects of WFS remain consistent.)
5. Pediatric Sepsis Guidelines: Weiss SL, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106.